Pilot study reveals IgGAM lowers infections and hospitalizations in PID patients, suggesting immunoglobulin preparations may help.
In patients with severe PID and undetectable IgA/IgM, IgGAM was associated with reduced infections and hospitalizations. Controlled studies are needed to confirm the benefit of IgA/M enriched immunoglobulin preparations in PID patients with persistent and/or recurrent respiratory or digestive infections.
No takes yet. Share an insight, caveat, or question.
Fieschi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: